244 related articles for article (PubMed ID: 32141631)
21. IgM and IgA rheumatoid factors purified from rheumatoid arthritis sera boost the Fc receptor- and complement-dependent effector functions of the disease-specific anti-citrullinated protein autoantibodies.
Anquetil F; Clavel C; Offer G; Serre G; Sebbag M
J Immunol; 2015 Apr; 194(8):3664-74. PubMed ID: 25769920
[TBL] [Abstract][Full Text] [Related]
22. Timing of Elevations of Autoantibody Isotypes Prior to Diagnosis of Rheumatoid Arthritis.
Kelmenson LB; Wagner BD; McNair BK; Frazer-Abel A; Demoruelle MK; Bergstedt DT; Feser ML; Moss LK; Parish MC; Mewshaw EA; Mikuls TR; Edison JD; Holers VM; Deane KD
Arthritis Rheumatol; 2020 Feb; 72(2):251-261. PubMed ID: 31464042
[TBL] [Abstract][Full Text] [Related]
23. Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive.
Hiwa R; Ohmura K; Nakabo S; Terao C; Murakami K; Nakashima R; Imura Y; Yukawa N; Yoshifuji H; Hashimoto M; Furu M; Ito H; Fujii T; Mimori T
Int J Rheum Dis; 2017 Jun; 20(6):731-736. PubMed ID: 28198158
[TBL] [Abstract][Full Text] [Related]
24. Asthma and elevation of anti-citrullinated protein antibodies prior to the onset of rheumatoid arthritis.
Zaccardelli A; Liu X; Ford JA; Cui J; Lu B; Chu SH; Schur PH; Speyer CB; Costenbader KH; Robinson WH; Sokolove J; Karlson EW; Camargo CA; Sparks JA
Arthritis Res Ther; 2019 Nov; 21(1):246. PubMed ID: 31753003
[TBL] [Abstract][Full Text] [Related]
25. Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis-related interstitial lung disease: a meta-analysis.
Xie S; Li S; Chen B; Zhu Q; Xu L; Li F
Clin Rheumatol; 2021 Nov; 40(11):4533-4543. PubMed ID: 34189672
[TBL] [Abstract][Full Text] [Related]
26. Anti-Citrullinated Protein Antibody Specificities, Rheumatoid Factor Isotypes, and Incident Cardiovascular Events in Patients With Rheumatoid Arthritis.
Westerlind H; Rönnelid J; Hansson M; Alfredsson L; Mathsson-Alm L; Serre G; Cornillet M; Holmdahl R; Jakobsson PJ; Skriner K; Klareskog L; Saevarsdottir S; Askling J
Arthritis Rheumatol; 2020 Oct; 72(10):1658-1667. PubMed ID: 32475073
[TBL] [Abstract][Full Text] [Related]
27. Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis.
Brink M; Hansson M; Mathsson-Alm L; Wijayatunga P; Verheul MK; Trouw LA; Holmdahl R; Rönnelid J; Klareskog L; Rantapää-Dahlqvist S
Arthritis Res Ther; 2016 Feb; 18():43. PubMed ID: 26860413
[TBL] [Abstract][Full Text] [Related]
28. B cell depletion with rituximab in patients with rheumatoid arthritis: Multiplex bead array reveals the kinetics of IgG and IgA antibodies to citrullinated antigens.
Cambridge G; Leandro MJ; Lahey LJ; Fairhead T; Robinson WH; Sokolove J
J Autoimmun; 2016 Jun; 70():22-30. PubMed ID: 27055777
[TBL] [Abstract][Full Text] [Related]
29. The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years.
da Mota LM; Dos Santos Neto LL; de Carvalho JF; Pereira IA; Burlingame R; Ménard HA; Laurindo IM
Rheumatol Int; 2012 Dec; 32(12):3807-12. PubMed ID: 22187055
[TBL] [Abstract][Full Text] [Related]
30. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders.
Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P
Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033
[TBL] [Abstract][Full Text] [Related]
31. Occurrence of anti-CCP2 and RF isotypes and their relation to age and disease severity among Sudanese patients with rheumatoid arthritis.
Elshafie AI; Elbagir S; Aledrissy MIE; Elagib EM; Nur MAM; Rönnelid J
Clin Rheumatol; 2019 Jun; 38(6):1545-1553. PubMed ID: 30656490
[TBL] [Abstract][Full Text] [Related]
32. Circulating anti-citrullinated protein antibodies containing secretory component are prognostic for arthritis onset in at-risk patients.
Roos Ljungberg K; Martinsson K; Wetterö J; Svärd A; Kastbom A
Clin Exp Immunol; 2021 Jun; 204(3):344-351. PubMed ID: 33675063
[TBL] [Abstract][Full Text] [Related]
33. Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study.
van Wesemael TJ; Ajeganova S; Humphreys J; Terao C; Muhammad A; Symmons DP; MacGregor AJ; Hafström I; Trouw LA; van der Helm-van Mil AH; Huizinga TW; Mimori T; Toes RE; Matsuda F; Svensson B; Verstappen SM; van der Woude D
Arthritis Res Ther; 2016 Dec; 18(1):285. PubMed ID: 27906045
[TBL] [Abstract][Full Text] [Related]
34. Antibodies against
Svärd A; Kastbom A; Ljungberg KR; Potempa B; Potempa J; Persson GR; Renvert S; Berglund JS; Söderlin MK
Front Immunol; 2023; 14():1183194. PubMed ID: 37325636
[TBL] [Abstract][Full Text] [Related]
35. Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope.
Lakos G; Soós L; Fekete A; Szabó Z; Zeher M; Horváth IF; Dankó K; Kapitány A; Gyetvai A; Szegedi G; Szekanecz Z
Clin Exp Rheumatol; 2008; 26(2):253-60. PubMed ID: 18565246
[TBL] [Abstract][Full Text] [Related]
36. Secretory antibodies to citrullinated peptides in plasma and saliva from rheumatoid arthritis patients and their unaffected first-degree relatives.
Svärd A; Roos Ljungberg K; Brink M; Martinsson K; Sjöwall C; Rantapää Dahlqvist S; Kastbom A
Clin Exp Immunol; 2020 Feb; 199(2):143-149. PubMed ID: 31605388
[TBL] [Abstract][Full Text] [Related]
37. Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example.
Boeters DM; Trouw LA; van der Helm-van Mil AHM; van Steenbergen HW
Arthritis Res Ther; 2018 May; 20(1):94. PubMed ID: 29724250
[TBL] [Abstract][Full Text] [Related]
38. Antibodies against citrullinated proteins in relation to periodontitis with or without rheumatoid arthritis: a cross-sectional study.
Lew PH; Rahman MT; Safii SH; Baharuddin NA; Bartold PM; Sockalingam S; Kassim NLA; Vaithilingam RD
BMC Oral Health; 2021 Jul; 21(1):360. PubMed ID: 34284769
[TBL] [Abstract][Full Text] [Related]
39. Serum IgG ACPA-IgM RF immune complexes were detected in rheumatoid arthritis patients positive for IgM ACPA.
Haraguchi A; Yamada H; Kondo M; Okazaki K; Fukushi JI; Oyamada A; Yoshikai Y; Nakashima Y
Clin Exp Rheumatol; 2018; 36(4):612-618. PubMed ID: 29465353
[TBL] [Abstract][Full Text] [Related]
40. IgA anti-citrullinated protein antibodies are associated with flares during DMARD tapering in rheumatoid arthritis.
Sokolova MV; Hagen M; Bang H; Schett G; Rech J; Steffen U;
Rheumatology (Oxford); 2022 May; 61(5):2124-2131. PubMed ID: 34508547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
